Homeobox (HOX) genes are evolutionarily conserved genes encoding transcription factors that regulate mammalian embryonic growth and development of the urogenital tract. In both humans and mice, HOXA11 persists in the adult reproductive tract and is thought to play an important role in maintaining tissue developmental plasticity by regulating the expression of genes involved in extracellular matrix metabolism in the reproductive organs. Previously, we have shown that HOXA11 is necessary for development of the uterosacral ligaments in mice and is deficient in women with pelvic organ prolapse. Therefore, we hypothesized that Hoxa11 regulates the synthesis and/or metabolism of collagens in the uterosacral ligaments and uterus, and tested this by establishing an in utero and peritoneal Hoxa11 gene knockdown system in C57/BL6 mice using vectors bearing Hoxa11 short hairpin RNA. Specific knockdown of Hoxa11 transcripts and protein levels were confirmed versus control vectors. Protein and mRNA expression of collagen types I and III exhibited significant decreases following Hoxa11 knockdown according to Western blot analysis and real-time PCR. Tissue inhibitor of matrix metalloproteinase 1 (MMP1) expression also exhibited a significant decrease. Gelatinase zymography confirmed increases in pro-MMP2 and MMP9, as well as activated MMP2, following Hoxa11 knockdown. These results reveal that Hoxa11 knockdown in the uterosacral ligaments and uterus increases extracellular matrix degradation. More importantly, it suggests a mechanism in the weakening of the pelvic floor support in women, because decreased HOXA11 gene expression has been reported to be associated with decreased collagen and increased MMP2 expression in the uterosacral ligaments of women with pelvic organ prolapse.
INTRODUCTION
Pelvic organ prolapse (POP) occurs when the uterosacral ligaments (USLs), the main support structure of the uterus and upper vagina, and fascial support of the distal female reproductive tract are compromised, resulting in descent of the uterus and vagina. This herniated condition has been observed in a variety of mammals, from rodents to primates and humans [1] [2] [3] . In women, POP negatively impacts quality of life, because distortion of the pelvic anatomy is associated with urinary and fecal incontinence, pelvic pain, and sexual dysfunction [2] . The number of American women with this condition was estimated to be 3.3 million in 2010 and is forecast to increase in the range of 4.9 million to 9.2 million by the year 2050 [3] . Thus, the annual direct costs of corrective surgery for POP pose a significant economic burden on the health care system [4, 5] .
Phenotypic changes in the USLs associated with POP include alterations of the pelvic floor extracellular matrix (ECM) involving aberrant expressions of collagen, metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and elastin [6] [7] [8] [9] [10] [11] [12] [13] . Determining the upstream regulation of the ECM genes will help elucidate the mechanisms involved in the development of POP, which are currently not clear.
The highly conserved homeobox (HOX) genes encode transcription factors that orchestrate tissue-specific differentiation during embryogenesis and homeostatic processes during adult life. Among other roles, the HOXA cluster of genes is responsible for the developmental differentiation of the paramesonephric duct into the urogenital tract, and function postnatally to maintain the necessary plasticity of the uterus and genital organs during the menstrual cycle and pregnancy. Specifically, HOXA11 coordinates uterine development and endometrial changes, including those required for implantation [14] [15] [16] . Mice are useful models for the study of the HOXA cluster genes because they have a gene organization similar to that of humans, and regulation of the anteroposterior patterning of the female genital tract is conserved [16] [17] [18] [19] .
The full complement of downstream targets involved in the differentiation and maintenance of the ECM in the female genital tract is not known. Interestingly, the HOX gene clusters have been associated with the regulation of collagen, a key ECM component. The five fibrillar collagen genes are linked with the four HOX clusters in the genome, with one collagen gene near each of the HOXA, HOXB, and HOXC clusters, and two near the HOXD cluster in humans [20] . It is thought that HOX regulation of collagen subtypes imparts regional differences in the mechanical properties of tissues. Further, HOXA family genes have been implicated in the regulation of expression of key proteins involved in dynamic tissue and ECM remodeling, including the MMPs and TIMPs, which inhibit MMP activity [21] [22] [23] [24] . Tissue remodeling is a continuous process, and a balance between matrix synthesis and breakdown is necessary to maintain the integrity of the genital tissue.
To date, we have demonstrated that in the USLs of women with POP, decreased expression of collagen type III alpha 1 (COL3A1) and increased expression of MMP2 are correlated with decreased expression of HOXA11. Conversely, constitutive expression of Hoxa11 in vitro resulted in increased Col3a1 expression and decreased Mmp2 expression [25] . Although decreased HOXA11 correlates with altered ECM expression in women with POP, a model for the genesis of loss of pelvic floor support is still lacking. We have also previously shown that Hoxa11 is required for normal development of the USLs in that mice bearing a deletion of the Hoxa11 gene do not develop USLs. Therefore, we developed a model of in vivo Hoxa11 silencing within the genital tract of female mice to determine whether decreased Hoxa11 expression in vivo would result in alterations in expression of collagen and MMP activity.
MATERIALS AND METHODS

Animal Care and In Vivo Hoxa11 Short Hairpin RNA Transfection
Nulliparous 12-wk-old wild-type C57 black mice were obtained from Charles River Laboratories International Inc. (Wilmington, MA). Experiments using mice were performed in accordance with the National Institutes for Health's Guide for the Care and Use of Laboratory Animals and with the approval of the Yale Animal Care and Use Committee.
Hoxa11 short hairpin RNA (shRNA) transfection media were prepared as follows: In solution 1, lipofectamine (Invitrogen, Grand Island, NY) was mixed with Opti-MEM (Invitrogen) to a final concentration of 7 ll/ml. In solution 2, four different Hoxa11 shRNA plasmids (OriGene Technologies Inc., Rockville, MD) were combined for use in Hoxa11 knockdown (KD) mice; an empty plasmid and a plasmid with a scrambled insert were combined for injection into control mice. These mixtures were added to Opti-MEM at 16 lg/ml. Solutions 1 and 2 were incubated at room temperature for 5 min and then combined in 1:1 proportion and further incubated at room temperature for 20 min.
Mice were anesthetized, and a low vertical abdominal incision was made. The uterine horns were exposed, and minimal manipulation of the uterus was performed to avoid stretching the uterine horns or USLs. Liposome-mediated gene transfection was used to deliver either the combined shRNA vectors with Hoxa11 inserts or the control vectors. The uterine horns were injected with 50 ll of transfection media each, and 400 ll of transfection media was injected into the peritoneal cavity to bathe the USLs before closing the abdomen. The USLs were not directly injected in order to avoid direct trauma to the USL architecture. The incision was closed with a running 4-0 vicryl stitch. A total of 18 mice were injected with Hoxa11 shRNA-inserted plasmid (Hoxa11 KD), and another 18 mice were injected with control plasmid (Fig. 1 ). Uteri and USLs were collected from six mice from each group at both 24 and 48 h after transfection. Additional USL samples were collected from another six control and six KD mice at 48 h specifically for protein extraction. All specimens were stored in RNAlater (Ambion, Austin, TX) and frozen at À808C until the time of the experiments. The uterus was bisected longitudinally in the midline, and one half of the uterine tissue was used for protein extraction, whereas the other half was used for RNA extraction. Total RNA was also extracted from USL tissues.
Real-Time PCR
Total RNA was isolated from uterine and USL tissues using the Trizol reagent (Invitrogen Corp., Carlsbad, CA). Total RNA was purified with RNeasy mini columns (Qiagen Inc., Valencia, CA) according to the manufacturer's protocol. For each sample, cDNA was produced from 1 lg of purified RNA using the iScript cDNA Synthesis Kit according to the manufacturer's protocol (Bio-Rad Laboratories Inc., Hercules, CA).
Messenger RNA levels of Hoxa11, Col1a1, Col1a2, Col3a1, tissue inhibitor of metalloproteinase 1 (Timp1), and Timp2 were measured via realtime PCR in uterine and USL tissues collected at both 24 and 48 h after transfection. All real-time PCR reactions were conducted in the Bio-Rad IQ5 Realtime-PCR Reaction System (Bio-Rad Laboratories). Reactions for each gene were run in duplicate. After confirming annealing temperatures for all primer pairs, the following protocol was applied to all real-time PCR reactions: preincubation at 958C for 3 min, followed by 40 cycles of denaturation at 958C for 10 sec, annealing at 608C for 30 sec, extension at 728C for 15 sec, and then incubation at 558C-958C with the melting temperature increasing 0.58C for each 10 sec. Real-time PCR data were analyzed through the standard 2 ÀDDCt method, where b-actin (Actb) was used as the internal control. Primers for all genes are listed in Table 1 [23, [25] [26] [27] .
Western Blotting
Harvested tissues were homogenized in a polytron homogenizer with 200 ll of ice-cold lysis buffer (50 mM Tris-HCl, 100 mM NaF, 1 mM MgCl 2 , 2.5 mM ethylene diamine tetraacetic acid, 100 mM NaCl, 2% SDS, 1% Nonidet P- 40, 0.5 M CaCl 2 , and 2 mM Na 3 VO 4 , pH 7.4). Homogenates were then clarified by centrifugation. Half of the homogenates were transferred into a fresh tube and boiled for 5 min to denature the protein extracts. The other half of the protein extracts consisted of nonheated native forms that were applied for gelatinase zymography. Native and denatured uterine protein extracts were quantified for concentrations via the standard bicinchoninic acid assay according to the manufacturer's protocol (Thermo Fisher Scientific Inc., Rockford, IL). Protein extracts were adjusted to a concentration of 2 lg/ll, and 23 sample loading buffer (125 mM Tris-HCl, 40% SDS, 20% glycerol, 0.05% bromophenol blue, and 10% b-mercaptoethanol) was added in a 1:1 proportion to the protein extracts. Sample loading buffer without b-mercaptoethanol was added to the native form of protein extracts. Protein levels of HOXA11, COLI, COLIII, and TIMP1 were measured in the posttransfection 24-and 48-h uteri as well as 48-h USL tissues via Western blotting. ACTB was used as an internal control. Western blot procedure was previously described in detail [28] . Briefly, 20 lg of protein was loaded from each sample for SDS-PAGE. Proteins were transferred to nitrocellulose membranes and were blocked with 5% skim milk and then incubated with the primary antibodies at 48C overnight, or at room temperature for 2-3 h. Those membranes were then incubated with secondary antibodies at room temperature for 1 h. Target protein signals were detected by the Western Lighting Plus-ECL Enhanced Chemiluminescence Substrate (PerkinElmer Inc., Waltham, MA) and exposed to HyBlot CL autoradiography films (Denville Scientific Inc., Metuchen, NJ). These films were then scanned into digital documents (HP ScanJet 5590; Hewlett-Packard Development Company L.P., Palo Alto, CA). Protein signal densities were measured via the ImageJ software (ImageJ 1.41 for MacOX; National Institutes of Health, Bethesda, MD), and the protein expression of interest was determined by normalizing with ACTB signal densities.
Primary antibodies against HOXA11 (Abcam Inc., Cambridge, MA), COLI and COLIII (Sigma-Aldrich, St. Louis, MO), and TIMP1 (Santa Cruz Biotechnology, Santa Cruz, CA) were all used at a 1:1000 dilution, and ACTB (Sungene Biotech, Tianjin, China) was used at a 1:5000 dilution. Secondary anti-mouse (Cell Signaling Technology, Boston, MA) and anti-goat (Santa Cruz Biotechnology) antibodies were both used at a 1:2000 dilution.
Gelatinase Zymography
Native protein extracts from 24 and 48 h posttransfection uterine tissues were applied for gelatinase zymography as described by Liotta and StetlerStevenson [29] . Briefly, 30 lg of protein from each sample was loaded and separated in 7.5% SDS-PAGEs containing 0.1% gelatin. Gels were washed in 2.5% Triton X-100 (Sigma-Aldrich) solution three times for 15 min. The gels were then incubated in the developing buffer (50 mM Tris-HCl, 5 mM CaCl 2 , and 0.05% Brij-35) at room temperature for 30 min, following 24 h of incubation in fresh developing buffer at 378C with gentle agitation. The gels were stained with 0.2% Coomassie brilliant blue staining solution (dissolved in methanol:acetic acid:distilled water in a 4:1:5 proportion), and destained to reveal the MMP2-and MMP9-digested area. Digital pictures were taken from the gels through the Kodak Gel Logic 100 Imaging System (Eastman Kodak Co., Rochester, NY), and signal densities of pro-MMP2, active MMP2, pro-MMP9, and active MMP9 were measured via the ImageJ software.
Statistical Analysis
Data were analyzed through a complete randomized design using General Linear Model of Statistical Analysis System (proc GLM; SAS 9.1; 2002-2003; SAS Institute Inc., Cary, NC). Mean separation was performed using least Hoxa11 REGULATES GENITAL TRACT MATRIX REMODELING significant means. Data are presented throughout as means 6 SEM and considered significantly different when P , 0.05.
RESULTS
Upon harvesting the tissue at 24 and 48 h, the Hoxa11 KD uteri were subjectively more translucent, edematous, and elastic compared with the controls. In addition, the USLs of KD mice appeared to be thinner and attenuated by visual inspection (Fig. 2) .
Delivery of shRNA Results in Decreased Hoxa11 Expression in the USLs and Uterus
In the USLs, Hoxa11 mRNA was very responsive to the shRNA delivery and decreased 54.6% and 49.9% at 24 and 48 h following transfection, respectively, compared with the control mice (P , 0.05; Fig. 3 ). In the uterus, Hoxa11 transcription was significantly decreased by 52% in the 24 h after transfection in Hoxa11 KD mice compared with the controls (P , 0.05; Fig. 3) . Similarly, HOXA11 protein levels exhibited significant decreases in both USLs and uteri 48 h after Hoxa11 KD (both P , 0.05; Fig. 4 ).
Expression of Collagen Types I and III in the USLs and Uterus after Hoxa11 KD
In the USLs, both Col1a2 and Col3a1 transcriptions were markedly reduced at 48 h after transfection in the Hoxa11 KD mice, exhibiting 84.6% and 90.5% decreases, respectively (P , 0.05), compared with control mice. Col1a1 mRNA expression was also decreased in the Hoxa11 KD USLs, but did not reach statistical significance (Fig. 5A) . In the 24-h uteri of Hoxa11 KD mice, mRNA expression of Col1a1 decreased significantly compared with controls, and this was the most affected subunit of the studied collagens (P , 0.05). Likewise, Col1a2 was also decreased at 24 h, and both Col1a2 and Col3a1 transcriptions were reduced at 48 h after transfection in the Hoxa11 KD mice, but these differences were not statistically significant.
Consistent with the mRNA expressions of Col1a1 and Col1a2, protein expressions of mature COLI (P , 0.05) were significantly decreased in the USLs of Hoxa11 KD versus control mice at 48 h (Fig. 6A) . The pro-COLI was also decreased in KD USLs at 48 h but was not statistically significant (P ¼ 0.06). In the uterus, mature COLI and mature COLIII were both reduced as a result of Hoxa11 KD at 24 h (P , 0.05; Fig. 6B ). Nonsignificant decreases were observed on protein expressions of COLI and COLIII at 48 h in the uteri (P , 0.10; Fig. 6C ).
FIG. 4. Posttransfection protein levels of HOXA11 in control and
Hoxa11 KD mice at 48 h in USLs and at 24 and 48 h in uteri. Means 6 SEM; n ¼ 6 per group. *P , 0.05. 
MA ET AL.
Expression and Activity of MMPs and Expression of TIMP1 after Hoxa11 KD
In the USLs at 24 h after transfection, mRNA expressions of Mmp2 and Timp2 were reduced 51.6% and 52%, respectively, in Hoxa11 KD versus control mice (P , 0.05; Fig. 7A) . However, at 48 h, Mmp2 mRNA expression was elevated more than 1.5-fold in the USLs of Hoxa11 KD mice compared with control mice (P , 0.05; Fig. 7A ). In the uterus, Mmp9 mRNA expression increased approximately 2-fold at 24 h after transfection in Hoxa11 KD versus control mice (P , 0.05; Fig. 7B ). Interestingly, following the dramatic increase at 24 h, Mmp9 mRNA expression in Hoxa11 KD mice was then repressed compared with control mice at 48 h after transfection FIG. 6 . Posttransfection protein levels of pro-COLI and pro-COLIII (both ;70 kDa) and their mature forms (both ;110 kDa) in control and Hoxa11 KD mice in USLs at 48 h (A), uteri at 24 h (B), and uteri at 48 h (C). Means 6 SEM; n ¼ 6 per group per time point. *P , 0.05.
Hoxa11 REGULATES GENITAL TRACT MATRIX REMODELING (P , 0.05; Fig. 7B ). Although Timp1 mRNA expression failed to show a difference at any time point in either tissue, TIMP1 protein expression was significantly reduced following Hoxa11 KD in the USLs at 48 h (P , 0.05; Fig. 8A ) and in the uteri at 24 and 48 h (P , 0.05; Fig. 8B ).
Gelatinase zymography revealed MMP activity results similar to the mRNA expression data for both MMP2 and MMP9. We found an increase in activated (P , 0.05) and total (P , 0.05) MMP2 protein levels in 48-h uteri upon Hoxa11 KD (Fig. 9A) . Pro-MMP2 was also increased at 48 h in KD mice; however, this was not statistically significant (P , 0.10; Fig. 9A ). Similarly, there were elevated pro-MMP and total MMP9 protein levels in 24-h uteri (P , 0.05; Fig. 9B ). No differences were observed in MMP2 protein levels in 24-h uteri (data not shown), which is consistent with its mRNA expression. In addition, MMP9 mRNA expression showed transient upregulation at 24 h along with Hoxa11 KD, which agrees with the elevated protein levels at 48 h in the uteri.
DISCUSSION
In the current study, we successfully knocked down Hoxa11 in the genital tract of mice and created a Hoxa11 and ECM expression profile that is similar to that in seen in the USLs in women with POP. The KD of Hoxa11 was specific, because a scrambled plasmid used in control mice did not lead to significant changes in gene expression, and in our KD mice we saw both elevations and reductions in their ECM expression profiles. Our data suggest that under normal conditions, Hoxa11 regulates the expression of MMPs and TIMPs in a manner that ultimately affects the levels of mature collagen in the genital tract.
The degradation of COLI and COLIII depends on the activity of the interstitial MMPs and the gelatinases, MMP2 and MMP9. MMP2 is capable of cleaving soluble, triplehelical COLI and generates the three-quarter-length and onequarter-length collagen fragments characteristic of the interstitial collagenases [30] . Expression of MMP2 has also been consistently shown to be increased in USLs in women with POP and has been implicated as a potential factor in altered collagen metabolism associated with this condition [7, 12, 31] .
In our system, we saw different mRNA responses of Mmp2 and Mmp9 following Hoxa11 KD in the USLs and uterus. Currently, we are not clear on the causes of transient reduction in the mRNA expression of Mmp2 at 24 h in the USLs prior to its increase at 48 h. Additionally, in the uterus of KD mice, we saw a transient dramatic increase in Mmp9 mRNA expression at 24 h followed by repression at 48 h. Thus, studies on the regulation of Hoxa11 downstream transcriptional targets are required to clarify these transient changes of Mmp genes at mRNA levels. In addition, it would be important to clarify the mechanism responsible for the different Mmp expressions seen between the USLs and the uterus, because this may be due to distinct posttranslational regulation that is specific to each tissue and its functions.
Because MMP9 activation was not significantly altered as seen on gel zymography, this suggests MMP2 as the prominent enzyme in the catabolism of mature collagens in the uterus. Unfortunately, because of the attenuation of the USLs in the Hoxa11 KD mice at the time of harvest, we were not able to reliably perform zymography in the USLs. However, our data from the uterine tissue suggesting regulation at the transcriptional, translational, and posttranslational levels of MMP expression warrant further investigation in USL tissue.
It is plausible that the increased MMP2 activity detected in KD uteri was in part due to the altered TIMP expression. TIMPs bind to the active site of the MMPs and block access to their extracellular substrates [32] . TIMP1 is the prototypic inhibitor for most MMP family members and is capable of inhibiting both MMP2 and MMP9, whereas TIMP2 is specific for inhibiting MMP2 [32] [33] [34] [35] . In the current study, Timp2 was markedly decreased during Hoxa11 KD in the 24-h USLs, which could potentially promote the activation of MMP2. Interestingly, TIMP1 was regulated at the posttranscriptional level in the USLs and uterus.
Additionally, as fibrillar collagens, COLI is a trimer composed of two alpha-1 chains and one alpha-2 chain, and COLIII is a homotrimer composed of three alpha-1 chains. Decreased synthesis of these fibrils would expectedly reduce the total COLI and COLIII content in the USLs and uterus. Alternatively, decreased collagen production in both USLs and uteri may be a result of decreased proliferation of fibroblasts, as our previous observations showed that Hoxa11 overexpression promoted cell proliferation in murine fibroblasts and in human primary USL cell cultures through a p53-dependent pathway [36] .
In summary, we found that in the mouse, Hoxa11 KD in tissues of the female reproductive tract results in altered mature collagen expression. In addition, altered MMP and TIMP expression and activity are suggestive of increased overall ECM degradation in the USLs and uteri upon Hoxa11 KD. This ECM expression profile mimics that in seen in the USLs in women with POP. This is the first study to provide evidence for a mechanism where an upstream transcriptional regulator, Hoxa11, controls collagen, and its regulatory enzymes involved ECM turnover in the pelvic floor in vivo. The successful KD of Hoxa11 and its effect on the ECM in the genital tract in these exploratory experiments provide the basis for future opportunities to determine the cascade of Hoxa11-mediated regulation of ECM homeostasis at the transcriptional, translational, and posttranslational levels in vivo. In addition, creating this murine model is another step toward our goal of determining how this relationship between Hoxa11 expression and ECM remodeling contributes to the biomechanical properties of the USLs and the development of POP in women. These data may also be useful for determining the role of Hoxa11 in ECM remodeling in the uterus during physiologic events, such as the menstrual cycle and implantation, which involve HOXA11 and MMP activity.
